Valuation: IOL Chemicals and Pharmaceuticals Limited

Market Cap 48.74B 511M 443M 415M 378M 712M 723M 4.89B 1.91B 24.4B 1.92B 1.88B 81.39B P/E 2027 *
22.1x
P/E 2028 * 17.1x
Enterprise Value 48.74B 511M 443M 415M 378M 712M 723M 4.89B 1.91B 24.4B 1.92B 1.88B 81.39B EV / Sales 2027 *
1.78x
EV / Sales 2028 * 1.55x
Free-Float
33.91%
Yield 2027 *
-
Yield 2028 * -
1 day-2.86%
1 week-3.87%
Current month+10.33%
1 month-7.11%
3 months+47.53%
6 months+115.61%
Current year+96.11%
1 week 155.8
Extreme 155.8
178.5
1 month 143.55
Extreme 143.55
179.65
Current year 67.14
Extreme 67.14
179.65
1 year 67.14
Extreme 67.14
179.65
3 years 57.51
Extreme 57.51
179.65
5 years 54.44
Extreme 54.44
179.65
10 years 8.4
Extreme 8.4
179.68
Manager TitleAgeSince
Chief Executive Officer 34 -
Director of Finance/CFO - -
Compliance Officer - 2019-11-13
Director TitleAgeSince
Chairman 63 2007-08-31
Director/Board Member 34 2015-05-28
Chairman 73 -
Change 5-day change 1-year change 3-year change Capi.($)
-2.86%-3.87%+75.04%+117.01% 511M
-0.92%+1.43%+83.05%+128.86% 1,078B
+0.47%+1.98%+50.26%+50.75% 632B
+0.83%+2.85%+24.49%+64.82% 443B
-0.88%-0.66%+45.09%+36.64% 356B
-0.37%-1.15%+26.89%+36.31% 289B
+0.05%-1.20%+2.31%+6.15% 245B
+0.40%+3.21%+44.42%+59.17% 226B
-0.42%+1.58%-8.48%-51.94% 204B
+1.67%+5.56%+14.98%+72.68% 171B
Average -0.20%+1.47%+35.80%+52.04% 364.42B
Weighted average by Cap. -0.12%+1.30%+45.94%+65.86%

Financials

2027 *2028 *
Net sales 27.42B 287M 249M 233M 213M 401M 407M 2.75B 1.07B 13.73B 1.08B 1.06B 45.79B 31.52B 330M 286M 268M 245M 460M 468M 3.16B 1.23B 15.78B 1.24B 1.21B 52.64B
Net income 2.2B 23.03M 19.96M 18.71M 17.06M 32.11M 32.62M 220M 86.02M 1.1B 86.46M 84.59M 3.67B 2.84B 29.76M 25.79M 24.18M 22.05M 41.48M 42.15M 285M 111M 1.42B 112M 109M 4.74B
Net Debt - -
Logo IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.
Employees
3,095
Date Price Change Volume
26-08-14 161.30 -2.86% 89,289
26-08-13 ₹166.05 +4.93% 159,958
26-08-12 ₹158.25 -3.21% 140,071
26-08-11 ₹163.50 -0.88% 304,677
26-08-10 ₹164.95 -1.70% 566,578
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
166.05INR
Average target price
197.00INR
Spread / Average Target
+18.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IOLCP Stock